Comparison of Serum Soluble Corin Levels among Stroke Subtypes
Journal Title: Journal of Neurology, Neurological Science and Disorders - Year 2015, Vol 1, Issue 1
Abstract
Background: Serum soluble corin was decreased not only in some cardiac diseases, but also in stroke. Cardiogenic sources play a critical role in ischemic stroke. Serum soluble corin level in stroke subtypes has not been studied. Here we aimed to study corin level in 4 stroke subtypes: hemorrhagic, thrombotic, embolic and lacunar stroke.
Authors and Affiliations
Hu Weidong, Zhang Peipei, Shi Jijun, Song Yulin, Zhu Fangfang, Han Xiujie, Zhou Dan, Liu Yan, Zhi Zhongwen, Shen Yun, Ma Juanjuan, Peng Hao
Comparing Staircase and Skilled Forelimb Reaching Tests After Endothelin-1-Induced Stroke
Background: Stroke is a leading cause of death and disability worldwide, but there are limited treatment options available despite extensive animal studies. A possible contributing factor for this discrepancy involves li...
Intratunnel Pressure Measurement in Patients with Carpal Tunnel Syndrome in Vietnam
Objective: Measure the intratunnel pressure of carpal tunnel in patients who underwent surgical treatment for carpal tunnel syndrome in Hanoi Medical University Hospital. Patients and method: Prospective cross-sectional...
Priorities in Movement Disorders Research
Objectives: To analyze the patterns of movement disorders prospectively using the registry of movement disorders in our institution and to identify some research priorities. Background and purpose: Movement disorders ar...
The Potential Role of Store-Operated Calcium Entry (SOCE) Pathways in the Pathophysiology of Epilepsy and Migraine-Like Headaches in Patients with Neurocysticercosis
Cysticercosis is the most common helminthic disease of the nervous system in humans. The clinical presentation of neurocysticercosis (NCC) is nonspecific and can mimic a wide array of primary central nervous system (CNS)...
Cytoprotection in Multiple Sclerosis and Ischemic Stroke with C-Phycocyanin and Phycocyanobilin
Cytoprotection in human diseases can be achieved by avoiding and ameliorating tissue damage or by restoring the homeostatic balance either as a local or a systemic defense response. Multiple Sclerosis (MS) and Ischemic S...